_id

69148633ccc777a4e85d962f

Ticker

OABIW

Name

OmniAb Inc.

Exchange

NASDAQ

Address

5980 Horton Street, EmeryVille, CA, United States, 94608

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.omniab.com

Description

OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune systems of its proprietary and engineered transgenic animals to create optimized antibody candidates for human therapeutics. The company's animal-based technologies include OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences; OmniFlic, a bispecific rat and OmniClic, a bispecific chicken are designed for discovery of bispecific antibody applications; OmniTaur, which provides cow-inspired antibodies with unique structural characteristics for challenging targets; OmnidAb, an in vivo platform for the discovery of single-domain antibodies based upon a human VH scaffold; and OmniDeep, a suite of in silico, an artificial intelligence (AI) and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. The company has an agreement with mAbsolve Ltd. for its Fc-silencing platform technology to incorporate the STR technology into antibodies that have been generated using OmniAb's antibody discovery platform. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.

Last Close

0.1199

Volume

102

Current Price

0.116

Change

0

Last Updated

2025-11-22T18:23:18.424Z

Image

data:image/webp;base64,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

Ipo Date

2021-09-30T00:00:00.000Z

Market Cap

-

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.999

Sentiment Sources

1

Current Quarter

2025-09-30

Revenue

2239000

Cost Of Revenue

4684000

Gross Profit

-2445000

Operating Expenses

15719000

Operating Income

-18164000

Interest Expense

-

Pretax Income

-15364001

Net Income

-16524999

Eps

-0.14403883165106426

Dividends Per Share

-

Shares Outstanding

114726000

Income Tax Expense

1160999

EBITDA

-10709001

Operating Margin

-811.2550245645376

Total Other Income Expense Net

2799999

Cash

28537000

Short Term Investments

30963000

Receivables

3095000

Inventories

443000

Total Current Assets

66349000

Property Plant Equipment

29397000

Total Assets

309690000

Payables

1908000

Short Term Debt

3861000

Long Term Debt

-

Total Liabilities

32246000

Equity

277444000

Depreciation

4655000

Change In Working Capital

-532000

Cash From Operations

-9763000

Capital Expenditures

182000

Cash From Investing

-7665000

Cash From Financing

27684000

Net Change In Cash

10256000

PE

-

PB

0.04796721500555067

ROE

-5.956156557719756

ROA

-5.335980819529206

FCF

-9945000

Fcf Percent

-4.441715051362215

Piotroski FScore

1

Health Score

34

Deep Value Investing Score

5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

5.3

Garp Investing Score

2.5

Growth Investing Score

1

Momentum Investing Score

4.5

Net Net Investing Score

2

Quality Investing Score

3

Value Investing Score

5.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

2239000

Quarters > 0 > income Statement > cost Of Revenue

4684000

Quarters > 0 > income Statement > gross Profit

-2445000

Quarters > 0 > income Statement > operating Expenses

15719000

Quarters > 0 > income Statement > operating Income

-18164000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-15364001

Quarters > 0 > income Statement > net Income

-16524999

Quarters > 0 > income Statement > eps

-0.14403883165106426

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

114726000

Quarters > 0 > income Statement > income Tax Expense

1160999

Quarters > 0 > income Statement > EBITDA

-10709001

Quarters > 0 > income Statement > operating Margin

-811.2550245645376

Quarters > 0 > income Statement > total Other Income Expense Net

2799999

Quarters > 0 > balance Sheet > cash

28537000

Quarters > 0 > balance Sheet > short Term Investments

30963000

Quarters > 0 > balance Sheet > receivables

3095000

Quarters > 0 > balance Sheet > inventories

443000

Quarters > 0 > balance Sheet > total Current Assets

66349000

Quarters > 0 > balance Sheet > property Plant Equipment

29397000

Quarters > 0 > balance Sheet > total Assets

309690000

Quarters > 0 > balance Sheet > payables

1908000

Quarters > 0 > balance Sheet > short Term Debt

3861000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

32246000

Quarters > 0 > balance Sheet > equity

277444000

Quarters > 0 > cash Flow > net Income

-16524999

Quarters > 0 > cash Flow > depreciation

4655000

Quarters > 0 > cash Flow > change In Working Capital

-532000

Quarters > 0 > cash Flow > cash From Operations

-9763000

Quarters > 0 > cash Flow > capital Expenditures

182000

Quarters > 0 > cash Flow > cash From Investing

-7665000

Quarters > 0 > cash Flow > cash From Financing

27684000

Quarters > 0 > cash Flow > net Change In Cash

10256000

Quarters > 0 > ratios > PE

-0.14403883165106426

Quarters > 0 > ratios > PB

0.04796721500555067

Quarters > 0 > ratios > ROE

-5.956156557719756

Quarters > 0 > ratios > ROA

-5.335980819529206

Quarters > 0 > ratios > FCF

-9945000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-4.441715051362215

Quarters > 0 > health Score

34

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

3897000

Quarters > 1 > income Statement > cost Of Revenue

262000

Quarters > 1 > income Statement > gross Profit

3635000

Quarters > 1 > income Statement > operating Expenses

19854000

Quarters > 1 > income Statement > operating Income

-16219000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-15756000

Quarters > 1 > income Statement > net Income

-15875000

Quarters > 1 > income Statement > eps

-0.14955533783019934

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

106148000

Quarters > 1 > income Statement > income Tax Expense

119000

Quarters > 1 > income Statement > EBITDA

-14570000

Quarters > 1 > income Statement > operating Margin

-416.1919425198871

Quarters > 1 > income Statement > total Other Income Expense Net

463000

Quarters > 1 > balance Sheet > cash

18281000

Quarters > 1 > balance Sheet > short Term Investments

23334000

Quarters > 1 > balance Sheet > receivables

2706000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

47618000

Quarters > 1 > balance Sheet > property Plant Equipment

30746000

Quarters > 1 > balance Sheet > total Assets

295674000

Quarters > 1 > balance Sheet > payables

1977000

Quarters > 1 > balance Sheet > short Term Debt

3844000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

33610000

Quarters > 1 > balance Sheet > equity

262064000

Quarters > 1 > cash Flow > net Income

-15875000

Quarters > 1 > cash Flow > depreciation

4649000

Quarters > 1 > cash Flow > change In Working Capital

3896000

Quarters > 1 > cash Flow > cash From Operations

-5146000

Quarters > 1 > cash Flow > capital Expenditures

165000

Quarters > 1 > cash Flow > cash From Investing

12299000

Quarters > 1 > cash Flow > cash From Financing

236000

Quarters > 1 > cash Flow > net Change In Cash

7389000

Quarters > 1 > ratios > PE

-0.14955533783019934

Quarters > 1 > ratios > PB

0.046985347090786986

Quarters > 1 > ratios > ROE

-6.057680566579156

Quarters > 1 > ratios > ROA

-5.369088929023181

Quarters > 1 > ratios > FCF

-5311000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-1.3628432127277392

Quarters > 1 > health Score

34

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

4154000

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

4154000

Quarters > 2 > income Statement > operating Expenses

22998000

Quarters > 2 > income Statement > operating Income

-18844000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-18306000

Quarters > 2 > income Statement > net Income

-18200000

Quarters > 2 > income Statement > eps

-0.1723125863929863

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

105622000

Quarters > 2 > income Statement > income Tax Expense

-106000

Quarters > 2 > income Statement > EBITDA

-14101000

Quarters > 2 > income Statement > operating Margin

-453.6350505536832

Quarters > 2 > income Statement > total Other Income Expense Net

538000

Quarters > 2 > balance Sheet > cash

10892000

Quarters > 2 > balance Sheet > short Term Investments

32703000

Quarters > 2 > balance Sheet > receivables

6478000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

53578000

Quarters > 2 > balance Sheet > property Plant Equipment

31950000

Quarters > 2 > balance Sheet > total Assets

306182000

Quarters > 2 > balance Sheet > payables

1933000

Quarters > 2 > balance Sheet > short Term Debt

3813000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

32666000

Quarters > 2 > balance Sheet > equity

273516000

Quarters > 2 > cash Flow > net Income

-18200000

Quarters > 2 > cash Flow > depreciation

4743000

Quarters > 2 > cash Flow > change In Working Capital

-5402000

Quarters > 2 > cash Flow > cash From Operations

-15872000

Quarters > 2 > cash Flow > capital Expenditures

209000

Quarters > 2 > cash Flow > cash From Investing

-878000

Quarters > 2 > cash Flow > cash From Financing

44000

Quarters > 2 > cash Flow > net Change In Cash

-16706000

Quarters > 2 > ratios > PE

-0.1723125863929863

Quarters > 2 > ratios > PB

0.04479501016393922

Quarters > 2 > ratios > ROE

-6.65408970590386

Quarters > 2 > ratios > ROA

-5.944176992769007

Quarters > 2 > ratios > FCF

-16081000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-3.8712084737602313

Quarters > 2 > health Score

34

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

10804000

Quarters > 3 > income Statement > cost Of Revenue

11050000

Quarters > 3 > income Statement > gross Profit

10804000

Quarters > 3 > income Statement > operating Expenses

26684000

Quarters > 3 > income Statement > operating Income

-15880000

Quarters > 3 > income Statement > interest Expense

3106000

Quarters > 3 > income Statement > pretax Income

-15223000

Quarters > 3 > income Statement > net Income

-13068000

Quarters > 3 > income Statement > eps

-0.12470060594494012

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

104795000

Quarters > 3 > income Statement > income Tax Expense

-2155000

Quarters > 3 > income Statement > EBITDA

-8274000

Quarters > 3 > income Statement > operating Margin

-146.98259903739356

Quarters > 3 > income Statement > total Other Income Expense Net

657000

Quarters > 3 > balance Sheet > cash

27598000

Quarters > 3 > balance Sheet > short Term Investments

31836000

Quarters > 3 > balance Sheet > receivables

5272000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

68138000

Quarters > 3 > balance Sheet > property Plant Equipment

33281000

Quarters > 3 > balance Sheet > total Assets

325558000

Quarters > 3 > balance Sheet > payables

2297000

Quarters > 3 > balance Sheet > short Term Debt

3782000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

37940000

Quarters > 3 > balance Sheet > equity

287618000

Quarters > 3 > cash Flow > net Income

-13068000

Quarters > 3 > cash Flow > depreciation

7606000

Quarters > 3 > cash Flow > change In Working Capital

-1379000

Quarters > 3 > cash Flow > cash From Operations

-3872000

Quarters > 3 > cash Flow > capital Expenditures

46000

Quarters > 3 > cash Flow > cash From Investing

385000

Quarters > 3 > cash Flow > cash From Financing

3849000

Quarters > 3 > cash Flow > net Change In Cash

362000

Quarters > 3 > ratios > PE

-0.12470060594494012

Quarters > 3 > ratios > PB

0.04226515725719531

Quarters > 3 > ratios > ROE

-4.543526483043482

Quarters > 3 > ratios > ROA

-4.01403129396298

Quarters > 3 > ratios > FCF

-3918000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-0.3626434653831914

Quarters > 3 > health Score

34

Valuation > metrics > PE

-0.14403883165106426

Valuation > metrics > PB

0.04796721500555067

Valuation > final Score

70

Valuation > verdict

95.2% Undervalued

Profitability > metrics > ROE

-5.956156557719756

Profitability > metrics > ROA

-24.90617643069225

Profitability > metrics > Net Margin

-7.3805265743635555

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.11622525626793155

Risk > metrics > Interest Coverage

-3.9020408163265308

Risk > final Score

44

Risk > verdict

High

Liquidity > metrics > Current Ratio

11.500953371468192

Liquidity > metrics > Quick Ratio

11.424163633211995

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

70

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

5

Prev Risks > 1

42

Prev Risks > 2

40

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T22:19:39.704Z